Valuation : Cogstate Limited

Market Cap 525M 378M 326M 306M 280M 524M 35.73B 3.62B 1.41B 18.33B 1.42B 1.39B 59.06B P/E 2027 *
24.6x
P/E 2028 * 20.2x
Enterprise Value 463M 334M 287M 270M 247M 462M 31.52B 3.19B 1.24B 16.17B 1.25B 1.23B 52.1B EV / Sales 2027 *
4.33x
EV / Sales 2028 * 3.68x
Free-Float
55.13%
Yield 2027 *
1.71%
Yield 2028 * 2.06%
1 day+0.65%
1 week-3.44%
Current month+0.32%
1 month+23.11%
3 months+23.60%
6 months+44.39%
Current year+36.73%
1 week 2.99
Extreme 2.99
3.22
1 month 2.49
Extreme 2.49
3.23
Current year 2.01
Extreme 2.01
3.23
1 year 1.69
Extreme 1.69
3.23
3 years 0.8
Extreme 0.795
3.23
5 years 0.8
Extreme 0.795
3.23
10 years 0.16
Extreme 0.155
3.23
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Buy

Director

3,600 0.0021%
5/20/26 Buy

Director

430 0.0003%
4/15/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%-3.44%+82.30%+100.65% 375M
-2.54%-2.84%-1.90%+14.52% 50.35B
-0.40%+1.03%+439.20%+499.20% 45.2B
-1.42%+2.30%+45.46%+19.36% 44.71B
-1.22%-2.31%+12.40%+71.48% 41.24B
+0.53%-1.67%+15.16%+49.88% 33.08B
-0.21%+9.14% - - 17.81B
-0.35%-1.56%+22.59%+116.19% 16.56B
-1.01%+0.50%+15.83%+27.98% 14.82B
-1.65%-1.03%+77.75%+37.63% 14B
Average -0.76%-0.52%+78.76%+104.10% 27.81B
Weighted average by Cap. -1.04%-0.66%+94.22%+121.62%

Financials

2027 *2028 *
Net sales 107M 77.17M 66.4M 62.48M 57.07M 107M 7.29B 738M 286M 3.74B 290M 283M 12.04B 122M 87.92M 75.66M 71.18M 65.02M 122M 8.3B 841M 326M 4.26B 330M 323M 13.72B
Net income 21.71M 15.65M 13.47M 12.67M 11.57M 21.65M 1.48B 150M 58.1M 758M 58.77M 57.48M 2.44B 26.49M 19.1M 16.43M 15.46M 14.12M 26.42M 1.8B 183M 70.9M 925M 71.71M 70.15M 2.98B
Net Debt -61.87M -44.6M -38.38M -36.11M -32.99M -61.71M -4.21B -427M -166M -2.16B -167M -164M -6.96B -75.6M -54.49M -46.89M -44.12M -40.3M -75.39M -5.15B -521M -202M -2.64B -205M -200M -8.5B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-09-04 A$3.090 +0.65% 153,974
26-09-03 A$3.070 -0.32% 301,335
26-09-02 A$3.080 +1.32% 196,626
26-09-01 A$3.040 -1.30% 178,175
26-08-31 A$3.080 -1.28% 126,051
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.090AUD
Average target price
3.570AUD
Spread / Average Target
+15.53%

Quarterly revenue - Rate of surprise